.css-1xsl8rf{width:100%;display:-webkit-box;display:-webkit-flex;display:-ms-flexbox;display:flex;-webkit-align-items:center;-webkit-box-align:center;-ms-flex-align:center;align-items:center;position:relative;overflow:hidden;background:var(--alert-bg);-webkit-padding-start:var(--chakra-space-4);padding-inline-start:var(--chakra-space-4);-webkit-padding-end:var(--chakra-space-4);padding-inline-end:var(--chakra-space-4);padding-top:var(--chakra-space-1);padding-bottom:var(--chakra-space-1);--alert-fg:var(--chakra-colors-orange-600);--alert-bg:var(--chakra-colors-orange-100);font-weight:var(--chakra-fontWeights-semibold);padding-left:var(--chakra-space-4);}.chakra-ui-dark .css-1xsl8rf:not([data-theme]),[data-theme=dark] .css-1xsl8rf:not([data-theme]),.css-1xsl8rf[data-theme=dark]{--alert-fg:var(--chakra-colors-orange-200);--alert-bg:rgba(251, 211, 141, 0.16);}@media screen and (min-width: 48em){.css-1xsl8rf{padding-left:var(--chakra-space-8);}}Bitte aktivieren Sie Javascript um alle Funktionen nutzen zu können und ihre Nutzererfahrung zu verbessern.

Univ.Prof. Mag.Dr.rer.nat Michaela Lackner

Innsbruck / AT

Institute of Hygiene and Medical Microbiology

Vorsitz

19.09.2024
14:00 – 15:00
Scientific sessions - DMykG
Resistenzen und Neue Wirkstoffe
Hörsaal 3

Weitere Beteiligungen

18.09.2024
Poster
PI-59
Saccharomyces cerevisiae fungemias in hospitalized patients
Clinical mycology, Epidemiology & clinical cases
18.09.2024
Poster
PI-53
Evaluation of a novel quadruplex pan-Mucorales, pan-Aspergillus and section Terrei specific qPCR-assay, targeting the mitochondrial genome
Clinical mycology, Diagnostics
19.09.2024
Poster
PII-58
Occurrence of environmental Mucorales with clinical relevance in Tyrol
Clinical mycology, Epidemiology & clinical cases
19.09.2024
Poster
PII-54
Design and establishment of mitochondrial genes as diagnostic markers for mucormycetes, aspergilli, Aspergillus section Terrei specific qPCR-assay
Clinical mycology, Diagnostics